Clinical Trial Update: Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Not Treated With Positive Airway Pressure (PAP) Therapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial to evaluate the efficacy and safety of GZR18 injection in obese adults with obstructive sleep apnea not treated with positive airway pres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Obstructive Sleep Apnea

Drugs mentioned

• GZR18 Injection

Snippet

Sponsor: Gan & Lee Pharmaceuticals. | Conditions: Obstructive Sleep Apnea (OSA) | Phase 3 | Status: NOT_YET_RECRUITING